04/04/2022
•2022Press Release
Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results
The Body Agency Collective, Visby Medical, Inc. and CCHCI observe National STD Awareness Month with women’s health initiative on US-Mexico border. CCHCI among first healthcare providers in the nation to adopt new handheld PCR technology to detect gonorrhea, chlamydia and trichomoniasis in a single visit.
![Placeholder-1 Placeholder-1](http://visbywpstaging.visbyon-site.net/wp-content/uploads/elementor/thumbs/Placeholder-1-qhtaeiohdzzjtvqlh35qrktphg0a08da1s82il9pi0.webp)
- More than 1 million STIs are acquired every day globally. In 2020, the World Health Organization (WHO) estimated 374 million new infections with one of four STIs: trichomoniasis (156 million), chlamydia (129 million), gonorrhea (82 million), and syphilis (7.1 million) (WHO).
- Trichomoniasis is estimated to be the most prevalent non-viral STI worldwide, affecting approximately 3.7 million persons in the United States (CDC), and although it can affect both women and men, it is significantly more common in women (CDC).
- In 2019, a total of 1,808,703 cases of chlamydia were reported in the U.S., making it the most common notifiable condition in the United States for that year (CDC).
- Rates of reported gonorrhea have increased 92.0% since the historic low in 2009. During 2018–2019, the overall rate of reported gonorrhea increased 5.7%. Rates increased among both males and females, in all regions of the United States, and among all ethnicity groups (CDC).
About Chiricahua Community Health Centers, Inc.
Chiricahua Community Health Centers, Inc. (CCHCI) is a mission driven Federally Qualified Health Center and a tax exempt not-for-profit 501(c)(3) organization. Founded in 1996 as a small, rural health clinic operating in a community center, CCHCI has since grown to become the largest primary care organization in southeastern Arizona, serving more than 30,000 patients annually. About 61 percent of CCHCI’s patients are on Medicaid or uninsured and more than 25 percent live below 200 percent of the federal poverty threshold. CCHCI operates fourteen fixed-site medical clinics, and seven mobile-medical and mobile-dental units, that serve patients throughout the more than 6200 square mile borderlands of Cochise County.About The Body Agency Collective
The Body Agency Collective is a 501(c)(3) nonprofit organization that works to empower youth with their sexual health and wellness. TBA Collective seeks the latest innovation, tests it, and then helps to scale domestically and globally. Current programs are located in Ukraine, United States, Sierra Leone and Afghanistan.About Visby Medical™
Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company’s proprietary technology development program culminated in the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home. For more information, visit www.visbymedical.com. Follow Visby Medical on LinkedIn; Facebook, and Twitter. Media Contacts: CCHCI Jane Montgomery – PR Specialist jmontgomery@cchci.org The Body Agency Collective Kate Roberts – Founder kate@thebodyagency.com (202) 390-8879 Visby Medical, Inc. Doug Hochstedler – Vice President, Health doug.hochstedler@porternovelli.com (317) 645-8665Read more articles & insights
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess its susceptibility to ciprofloxacin.
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.
Visby Medical Expands Series E Round to Over $135 Million
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.